FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 101 through 150 of 309

BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES - SIC # 2836

Ticker Exchange Company Financial Reports SIC #
DAWN Nasdaq Day One Biopharmaceuticals, Inc. 2836
DBVT Nasdaq DBV Technologies S.A. 2836
DMAC Nasdaq DiaMedica Therapeutics Inc. 2836
DNA New York Ginkgo Bioworks Holdings, Inc. 2836
DNTH Nasdaq Dianthus Therapeutics, Inc. 2836
DRUG Nasdaq Bright Minds Biosciences Inc. 2836
DSGN Nasdaq Design Therapeutics, Inc. 2836
DTIL Nasdaq Precision BioSciences, Inc. 2836
DVAX Nasdaq Dynavax Technologies Corporation 2836
DYN Nasdaq Dyne Therapeutics, Inc. 2836
EDSA Nasdaq Edesa Biotech, Inc. 2836
ELUT Nasdaq Elutia Inc. 2836
ENSC Nasdaq Ensysce Biosciences, Inc. 2836
ENTX Nasdaq Entera Bio Ltd. 2836
EQ Nasdaq Equillium, Inc. 2836
ERAS Nasdaq Erasca, Inc. 2836
ERNA Nasdaq Ernexa Therapeutics Inc. 2836
ESLA Nasdaq Estrella Immunopharma, Inc. 2836
ESPR Nasdaq Esperion Therapeutics, Inc. 2836
EVGN Nasdaq Evogene Ltd. 2836
EXOZ Nasdaq eXoZymes, Inc. 2836
FBIO Nasdaq Fortress Biotech, Inc. 2836
FENC Nasdaq Fennec Pharmaceuticals Inc. 2836
FHTX Nasdaq Foghorn Therapeutics Inc. 2836
FOLD Nasdaq Amicus Therapeutics, Inc. 2836
FULC Nasdaq Fulcrum Therapeutics, Inc. 2836
GANX Nasdaq Gain Therapeutics, Inc. 2836
GELS Nasdaq Gelteq Limited 2836
GERN Nasdaq Geron Corporation 2836
GILD Nasdaq Gilead Sciences, Inc. 2836
GLSI Nasdaq Greenwich LifeSciences, Inc. 2836
GLTO Nasdaq Galecto, Inc. 2836
GLUE Nasdaq Monte Rosa Therapeutics, Inc. 2836
GMAB Nasdaq Genmab A/S 2836
GNFT Nasdaq Genfit S.A. 2836
GNPX Nasdaq Genprex, Inc. 2836
GOSS Nasdaq Gossamer Bio, Inc. 2836
GOVX Nasdaq GeoVax Labs, Inc. 2836
GRAL Nasdaq GRAIL, Inc. 2836
GRFS Nasdaq Grifols, S.A. 2836
GRI Nasdaq GRI Bio, Inc. 2836
GTBP Nasdaq GT Biopharma, Inc. 2836
HALO Nasdaq Halozyme Therapeutics, Inc. 2836
HOTH Nasdaq Hoth Therapeutics, Inc. 2836
HRGN Over the counter Harvard Apparatus Regenerative Technolog 2836
HUMA Nasdaq Humacyte, Inc. 2836
HURA Nasdaq TuHURA Biosciences, Inc. 2836
IBO NYSE American Impact BioMedical Inc. 2836
IBRX Nasdaq ImmunityBio, Inc. 2836
IGC NYSE American IGC Pharma, Inc. 2836
Results 100 through 150 of 309